EN DE
STOCK COMPARISON

Daesung Microbiological Labs. Co. vs Vertex Pharmaceuticals: Fair Value & Quality

Both stocks run through our valuation models. Here is how Daesung Microbiological Labs. Co. (036480) and Vertex Pharmaceuticals (VRTX) compare, as of Sep 25, 2026.

As of Sep 25, 2026, Fair Value Calculator sees Vertex Pharmaceuticals as the more attractively valued of the two: Daesung Microbiological Labs. Co. trades at KRW 6,040 versus a fair value of KRW 2,395 (-60%), while Vertex Pharmaceuticals trades at $516 versus $566 (+10%).
Daesung Microbiological Labs. Co.
036480.KQ · KRW · Health Care
-60%
upside to fair value
overvalued
PriceKRW 6,040
Fair ValueKRW 2,395
Quality61/100
Vertex Pharmaceuticals
VRTX · USD · Health Care
+10%
upside to fair value
fairly valued
Price$516
Fair Value$566
Quality79/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

Daesung Microbiological Labs. Co.Vertex Pharmaceuticals
Valuation
n/aP/E (TTM)30.7×
n/aP/E ex one-offs (FY2025)30.7×
n/aP/S (TTM)10.90×
n/aP/B7.14×
3.3×EV/EBITDA25.8×
n/aPEG1.72×
−60.3%Fair value upside+9.7%
1.2%Dividend yieldn/a
KRW 75Dividend per sharen/a
Profitability
-10%Operating margin38%
0.35×EBIT margin trend (5Y)0.86×
2%Return on equity24%
1%Return on assets12%
Growth
-2%Revenue growth (YoY)8%
0.6%Avg. growth/yr (3Y)10.6%
0.9%Avg. growth/yr (5Y)14.2%
−15.8%Value creation/yr+13.5%
Balance & size
1.2×Interest coverage (EBIT/interest)357.9×
0.38×Debt / equity0.03×
$16MMarket cap$133B
weakGrowth qualityhealthy
The P/E excluding one-off items is only shown where the special items are documented in the accounts (our own raw data or SEC filings). If one side lacks it, the reported P/E stays scored.

Vertex Pharmaceuticals leads: 1 to 10 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Daesung Microbiological Labs. Co.of which business quality 59 · market factors 30 Vertex Pharmaceuticalsof which business quality 77 · market factors 73
ProfitabilityMargins and returns on capital today
22
72
Quality GrowthAre margins and returns improving?
77
65
CashflowEarnings quality: real cash, not paper profit
57
79
Fin. StrengthBalance sheet, leverage, solvency risk
49
92
InvestmentDisciplined investing over empire-building
100
58
Low VolatilityCalm price path (market factor)
65
85
MomentumPrice trend over the last 3–12 months (market factor)
18
65
52W MomentumDistance to the 52-week high (market factor)
10
75
Net IssuanceShare count: buybacks or dilution?
82
82

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyDaesung Microbiological Labs. Co.Price KRW 6,040Vertex PharmaceuticalsPrice $516
DCF Models-76%below the priceKRW 1,472-12%close to the price$453
Earnings-Based-74%below the priceKRW 1,5420%close to the price$516
Multiples-56%below the priceKRW 2,676-46%below the price$278
Asset-Based+3%close to the priceKRW 6,245-90%below the price$49.27
Growth DCF-80%below the priceKRW 1,216-32%below the price$349
Economic Profit-1%close to the priceKRW 5,984-53%below the price$245
Growth Earnings-57%below the priceKRW 2,616+34%above the price$692
Minimum-80%below the priceKRW 1,216-90%below the price$49.27
Maximum+3%close to the priceKRW 6,245+34%above the price$692
Median-57%below the priceKRW 2,616-32%below the price$349
Geometric mean-58%below the priceKRW 2,561-43%below the price$294

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Daesung Microbiological Labs. Co.: 15 of 19 models see the stock below the current price.

Vertex Pharmaceuticals: 19 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Daesung Microbiological Labs. Co.
Price KRW 6,040
Fair Value KRW 2,395
Bear KRW 1,084Bull KRW 4,329
Vertex Pharmaceuticals
Price $516
Fair Value $566
Bear $340Bull $1,226

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Daesung Microbiological Labs. Co. · Health Care

Quality score61 · above median
Fair value upside-60% · bottom 25%

Vertex Pharmaceuticals · Health Care

Quality score79 · Top 25%
Fair value upside+10% · above median

Bottom line

As of Sep 25, 2026, Fair Value Calculator sees Vertex Pharmaceuticals as the more attractively valued of the two: Daesung Microbiological Labs. Co. trades at KRW 6,040 versus a fair value of KRW 2,395 (-60%), while Vertex Pharmaceuticals trades at $516 versus $566 (+10%).

Vertex Pharmaceuticals has the higher quality score (79/100).

Open Vertex Pharmaceuticals live analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.